6 Recruiting Studies Using Mogamulizumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Mogamulizumab
🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of VG712 in Patients With Mycosis Fungoides
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
Mycosis Fungoides
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
📍 University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan
Cutaneous T Cell Lymphoma
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Recurrent Adult T-Cell Leukemia/Lymphoma
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
📍 Memorial Sloan Kettering at Basking Ridge (All protocol activities) — Basking Ridge, New Jersey
T-Cell Leukemia/Lymphoma, Adult
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
📍 Stanford Cancer Center — Stanford, California
Sezary Syndrome
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
📍 Yale Cancer Center, Clinical Trials Office — New Haven, Connecticut
T Cell Lymphoma
View Study & Checklist ➔